newsfilter
← Latest News
PR Newswire·

Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta

First provincial public listing secured for both asthma medications Additional provincial public reimbursement coverage expected to follow soon 85% private payer health plan coverage across Canada MONTREAL, Nov. 3, 2021 /PRNewswire/ - Valeo Pharm